Plasma HSP70 Levels Correlate with Health Risk Factors and Insulin Resistance in African American Subjects

Abstract

The family of heat shock proteins works at the cellular level to protect cells against many chronically and acutely induced stressful conditions. The induction of certain family members, such as HSP70 and HSP90 via a heat shock factor 1 activated pathway, may have broad therapeutic benefits in the treatment of various types of tissue trauma and metabolic diseases. HSPs with their ability to improve cytoprotective functions and enhance tissue regeneration, offer a new potential in treating conditions such as diabetes and obesity. We hypothesized that the plasma levels of HSP70 and/or HSP90 would be significantly lower in obese than non-obese African American men and women. The objective of the study was to provide an analysis of plasma HSP70 and HSP90 concentrations of African American subjects grouped according to widely accepted health risk indices and insulin resistance. Comparisons of HSP70 and HSP90 concentrations by BMI, percent body fat, waist circumference, insulin resistance, plasma cortisol levels and gender were conducted. HSP70 concentration inversely correlated with BMI, percentage body fat, waist circumference, and insulin resistance. No significant correlation was observed for HSP90 concentration with the aforementioned indices. Our results show that high risk health conditions, such as obesity and type-2 diabetes, may be associated with compromised expression of specific heat shock proteins such as HSP70.

Key words

heat shock proteins - plasma - obesity - diabetes

• References

• 1 Atalay M, Oksala NK, Laaksonen DE et al. Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol 2004; 97: 605-611
• 2 Ceriello A, Bortolotti N, Falleti E et al. Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care 1997; 20: 194-197
• 3 Dandona P, Thusu K, Cook S et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347: 444-445
• 4 Kennedy AL, Lyons TJ. Glycation, oxidation, and lipoxidation in the development of diabetic complications. Metabolism 1997; 46 (Suppl. 01) 14-21
• 5 Islam A, Chen Y, Poth M et al. Glucocorticoid receptor density correlates with health risk factors and insulin resistance in Caucasian and African American subjects. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 2012; 120: 477-481
• 6 Avila C, Huang RJ, Stevens MV et al. Platelet mitochondrial dysfunction is evident in type 2 diabetes in association with modifications of mitochondrial anti-oxidant stress proteins. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 2012; 120: 248-251
• 7 Tyedmers J. Yeast as a model to understand mechanisms and consequences of protein modifications by metabolism derived toxic products. Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 2012; 120: 179-181
• 8 Atalay M, Oksala N, Lappalainen J et al. Heat shock proteins in diabetes and wound healing. Curr Protein Pept Sci 2009; 10: 85-95
• 9 Hooper PL, Hooper JJ. Loss of defense against stress: diabetes and heat shock proteins. Diabetes Technol Ther 2005; 7: 204-208
• 10 Hooper PL. Inflammation, heat shock proteins, and type 2 diabetes. Cell stress & chaperones 2009; 14: 113-115
• 11 Islam A, Abraham P, Hapner CD et al. Heat exposure induces tissue stress in heat-intolerant, but not heat-tolerant, mice. Stress 2013; 16: 244-253
• 12 Lindquist S. The heat-shock response. Annu Rev Biochem 1986; 55: 1151-1191
• 13 Morimoto RI. Cells in stress: transcriptional activation of heat shock genes. Science 1993; 259: 1409-1410
• 14 Parsell DA, Lindquist S. The function of heat-shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu Rev Genet 1993; 27: 437-496
• 15 Srivastava P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002; 20: 395-425
• 16 Welsh N, Margulis B, Borg LA et al. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol Med 1995; 1: 806-820
• 17 Hooper PL. Diabetes, nitric oxide, and heat shock proteins. Diabetes Care 2003; 26: 951-952
• 18 Kurucz I, Morva A, Vaag A et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 2002; 51: 1102-1109
• 19 Chen Y, Voegeli TS, Liu PP et al. Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm Allergy Drug Targets 2007; 6: 91-100
• 20 Anckar J, Sistonen L. Heat shock factor 1 as a coordinator of stress and developmental pathways. Adv Exp Med Biol 2007; 594: 78-88
• 21 Chung J, Nguyen AK, Henstridge DC et al. HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci USA 2008; 105: 1739-1744
• 22 Lee JH, Gao J, Kosinski PA et al. Heat shock protein 90 (HSP90) inhibitors activate the heat shock factor 1 (HSF1) stress response pathway and improve glucose regulation in diabetic mice. Biochem Biophys Res Commun 2013; 430: 1109-1113
• 23 Qin HY, Mahon JL, Atkinson MA et al. Type 1 diabetes alters anti-hsp90 autoantibody isotype. J Autoimmun 2003; 20: 237-245
• 24 Frazier B, Hsiao CW, Deuster P et al. African Americans and Caucasian Americans: differences in glucocorticoid-induced insulin resistance. Horm Metab Res 2010; 42: 887-891
• 25 Siegel JM, Yancey AK, McCarthy WJ. Overweight and depressive symptoms among African-American women. Prev Med 2000; 31: 232-240
• 26 Dai CY, Huang JF, Hsieh MY et al. Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients. J Hepatol 2009; 50: 712-718
• 27 Kim-Dorner SJ, Deuster PA, Zeno SA et al. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance?. Metabolism 2010; 59: 299-304
• 28 Eriksson J, Franssila-Kallunki A, Ekstrand A et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-343
• 29 Lillioja S, Mott DM, Spraul M et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 1993; 329: 1988-1992
• 30 Pi-Sunyer FX. Obesity: criteria and classification. Proc Nutr Soc 2000; 59: 505-509
• 31 Zhu S, Wang Z, Heshka S et al. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 2002; 76: 743-749
• 32 Petersen KF, Dufour S, Befroy D et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-671
• 33 Sinha R, Dufour S, Petersen KF et al. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 2002; 51: 1022-1027
• 34 Hirosumi J, Tuncman G, Chang L et al. A central role for JNK in obesity and insulin resistance. Nature 2002; 420: 333-336
• 35 Itani SI, Ruderman NB, Schmieder F et al. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002; 51: 2005-2011
• 36 Schmitz-Peiffer C. Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Ann N Y Acad Sci 2002; 967: 146-157
• 37 Shoelson SE, Lee J, Yuan M. Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord 2003; 27 (Suppl. 03) S49-S52
• 38 McCarty MF. Induction of heat shock proteins may combat insulin resistance. Med Hypotheses 2006; 66: 527-534
• 39 Kavanagh K, Flynn DM, Jenkins KA et al. Restoring HSP70 deficiencies improves glucose tolerance in diabetic monkeys. Am J Physiol Endocrinol Metab 2011; 300: E894-E901
• 40 Henstridge DC, Forbes JM, Penfold SA et al. The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposity. Metabolism 2010; 59: 1556-1561
• 41 Simar D, Jacques A, Caillaud C. Heat shock proteins induction reduces stress kinases activation, potentially improving insulin signalling in monocytes from obese subjects. Cell stress & chaperones 2012; 17: 615-621
• 42 Urban MJ, Li C, Yu C et al. Inhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic mice. ASN Neuro 2010; 2: e00040
• 43 Gruden G, Barutta F, Pinach S et al. Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study. Cell stress & chaperones 2013; 18: 353-357
• 44 Joly AL, Wettstein G, Mignot G et al. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. Journal of innate immunity 2010; 2: 238-247
• 45 De Maio A. Extracellular heat shock proteins, cellular export vesicles, and the Stress Observation System: a form of communication during injury, infection, and cell damage. It is never known how far a controversial finding will go! Dedicated to Ferruccio Ritossa. Cell stress & chaperones 2011; 16: 235-249
• 46 Nickel W, Seedorf M. Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annual review of cell and developmental biology 2008; 24: 287-308
• 47 Mambula SS, Calderwood SK. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes. Journal of immunology 2006; 177: 7849-7857
• 48 Evdonin AL, Martynova MG, Bystrova OA et al. The release of Hsp70 from A431 carcinoma cells is mediated by secretory-like granules. European journal of cell biology 2006; 85: 443-455
• 49 Vega VL, Rodriguez-Silva M, Frey T et al. Hsp70 translocates into the plasma membrane after stress and is released into the extracellular environment in a membrane-associated form that activates macrophages. Journal of immunology 2008; 180: 4299-4307
• 50 Almeida MB, do Nascimento JL, Herculano AM et al. Molecular chaperones: toward new therapeutic tools. Biomed Pharmacother 2011; 65: 239-243